Growth Metrics

OmniAb (OABI) Cash from Financing Activities (2021 - 2025)

OmniAb (OABI) reported Cash from Financing Activities of -$50000.0 for Q4 2025, down 101.3% year-over-year from $3.8 million in Q4 2024, and down 100.18% on a QoQ basis from $27.7 million in Q3 2025.

OmniAb (OABI) has 5 years of Cash from Financing Activities data on file, last reported at -$50000.0 in Q4 2025.

  • Quarterly Cash from Financing Activities fell 101.3% year-over-year to -$50000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $27.9 million (up 110.07% YoY) and the FY2025 annual result came in at $27.9 million, up 114.39% from the prior year.
  • Cash from Financing Activities retreated to -$50000.0 in Q4 2025 per OABI's latest filing, from $27.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $237.0 million in Q3 2021 and bottomed at -$227.4 million in Q4 2021.
  • The 5-year median for Cash from Financing Activities is $357000.0 (2023), against an average of $8.9 million.
  • The widest annual swing landed in 2024, when Cash from Financing Activities soared 4912.28%; it then plunged 101.3% in 2025.
  • Tracing OABI's Cash from Financing Activities over 5 years: stood at -$227.4 million in 2021, then soared by 144.5% to $101.2 million in 2022, then slumped by 100.49% to -$496000.0 in 2023, then surged by 876.01% to $3.8 million in 2024, then slumped by 101.3% to -$50000.0 in 2025.
  • Per Business Quant, the three latest OABI Cash from Financing Activities figures stand at -$50000.0 (Q4 2025), $27.7 million (Q3 2025), and $236000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 7.00 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -600,000.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 53,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -538.80 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -802.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.71 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -50,000.00
Dec 31, 2025 -50,000.00
Sep 30, 2025 27.68 Mn
Sep 30, 2025 27.68 Mn
Jun 30, 2025 236,000.00
Jun 30, 2025 236,000.00
Mar 31, 2025 44,000.00
Mar 31, 2025 44,000.00
Dec 31, 2024 3.85 Mn
Dec 31, 2024 3.85 Mn
Sep 30, 2024 8.57 Mn
Sep 30, 2024 8.57 Mn
Jun 30, 2024 803,000.00
Jun 30, 2024 803,000.00
Mar 31, 2024 -203,000.00
Mar 31, 2024 -203,000.00
Dec 31, 2023 -496,000.00
Dec 31, 2023 -496,000.00
Sep 30, 2023 171,000.00
Sep 30, 2023 171,000.00
Jun 30, 2023 478,000.00
Jun 30, 2023 478,000.00
Mar 31, 2023 -1.05 Mn
Mar 31, 2023 -1.05 Mn
Dec 31, 2022 101.18 Mn
Dec 31, 2022 101.18 Mn
Sep 30, 2022 9.11 Mn
Sep 30, 2022 9.11 Mn
Jun 30, 2022 8.14 Mn
Jun 30, 2022 8.14 Mn
Mar 31, 2022 -7.69 Mn
Mar 31, 2022 -7.69 Mn
Dec 31, 2021 -227.38 Mn
Dec 31, 2021 -227.38 Mn
Sep 30, 2021 237.04 Mn
Sep 30, 2021 237.04 Mn